0
0.5
1
1.5
2+
Progression
-165%
Improvement
Relative Risk
Sotrovimab Zaqout et al. EARLY TREATMENT
Is early treatment with sotrovimab beneficial for COVID-19?
Retrospective 928 patients in Qatar (October 2021 - February 2022)
Higher progression with sotrovimab (not stat. sig., p=0.19)
c19early.org
Zaqout et al., Int. J. Infectious Dise.., Apr 2022
Favors sotrovimab
Favors control